Baxter Ventures
Profile and fund size
Baxter Ventures is the corporate venture arm of Baxter International, a healthcare company. It was founded in 2011 and is based in Deerfield, United States. It invests from seed to Series A. Sectors it names: medical devices, healthcare and digital health, biotech and life sciences.
- Commitment by parentS2
- USD 200M
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Seed to Series A |
| Sectors | Medical devices, Healthcare and digital health, Biotech and life sciences |
| Geography | Global |
| Offices | Deerfield, United States |
Sources: S2 Baxter establishes Baxter Ventures to invest in early-stage therapies; S1 Baxter Ventures (Baxter site).
Where it invests
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | Baxter International (NYSE: BAX) | Single source | S1 |
| Parent industry | Healthcare and life sciences | Single source | S1 |
| Founded | 2011 | Single source | S1 |
| Headquarters | Deerfield, United States | Single source | S2 |
| Status | Active | Single source | S1 |
| Capital source | Parent company only | Single source | S1 |
| Headline size | USD 200M (Commitment by parent) | Single source | S2 |
| Stages | Seed, Series A (inferred from announced rounds) | Estimate | S2 |
About Baxter International
For founders
| Item | What the firm says | Source |
|---|---|---|
| Stages | Seed, Series A. Inferred from announced rounds; the firm does not state a range. | S2 |
| Pitch page | www.baxter.at/en/our-story/fueling-collaborative-innovation/baxter-ventures | S1 |
History
- Baxter International established Baxter VenturesS2
Official pages
Read the firm's own pages for current information.
- Website www.baxter.at/en/our-story/fueling-collaborative-innovation/baxter-ventures
Sources
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Baxter Ventures or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.